Annals of Medical and Surgical Dermatology

ABSTRACT

Antifungal remedy has evolved significantly in recent times, driven by the adding frequence of fungal infections and the limitations of traditional treatments. This review explores the rearmost advancements in antifungal agents, fastening on new and arising curatives designed to overcome being challenges, including medicine resistance and limited efficacity of aged medicines. We bandy the development of new medicine classes, similar as echinocandins and new azoles, as well as promising agents in clinical trials, including fosmanogepix and Rezafungin. The mechanisms of action of these arising curatives are examined, with an emphasis on their capability to target specific fungal pathways and alleviate resistance. also, the review highlights the eventuality of combination curatives, substantiated treatment approaches, and innovative medicine delivery systems to enhance treatment issues. Despite these advancements, challenges remain, including issues of cost, availability, and long- term safety. In conclusion, while the geography of antifungal remedy is fleetly evolving, farther exploration is pivotal to completely realize the eventuality of these arising treatments in clinical practice.

Article History

Received 18 July 2024; Revised 07 August 2024; Accepted 14 August 2024

KEYWORDS

1. Antifungal therapy
2. Emerging antifungal agents
3. Drug resistance
4. Echinocandins
5. Azoles Novel antifungal drugs